Target Healthcare REIT (LON:THRL – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 113 and last traded at GBX 110.60, with a volume of 34288 shares trading hands. The stock had previously closed at GBX 110.76.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group restated a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a report on Wednesday, May 6th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Target Healthcare REIT has an average rating of “Hold” and an average price target of GBX 101.
Read Our Latest Research Report on THRL
Target Healthcare REIT Stock Performance
Target Healthcare REIT Company Profile
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Read More
- Five stocks we like better than Target Healthcare REIT
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
